Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Karolinska Institutet researchers contribute at ESOF 2010

Researchers and staff from Karolinska Institutet are contributing to Europe's largest cross-disciplinary gathering place with news of everything from neuroscience to bioentrepreneurship. Carl Johan Sundberg, university lecturer and associate professor at Karolinska Institutet, is the founder and initiator of ESOF.

3 Jul 2010

VA to develop fully automated, online system for handling disability compensation claims

Secretary of Veterans Affairs Eric K. Shinseki announced today plans to develop a fully automated, online system for handling Veterans' disability compensation claims. More than a simple digitization of existing paper-based claims, the new system is part of VA's modernization of the end-to-end processing workflow. Automation will substantially reduce processing time and increase accuracy while simplifying the way that Veterans interact with the claims process.

3 Jul 2010

States anxiously hoping for extra Medicaid funds extension

Kaiser Health News: "Democrats are leaving Washington for their July 4th recess without passing key parts of their health agenda. Among the provisions being left for when Congress returns from a week-long break: enhanced Medicaid aid for states and a subsidy to help the laid off afford to keep their former employer's health insurance.

3 Jul 2010

XenoPort reports equity awards to new employee under Inducement Award Plan

XenoPort, Inc. reported today that equity awards were made to a new employee subject to the terms and conditions of the XenoPort 2010 Inducement Award Plan. The employee was granted options to purchase an aggregate of 75,000 shares of XenoPort's common stock and restricted stock units representing an aggregate of 5,000 shares of XenoPort's common stock.

2 Jul 2010

Parkinson's Disease Foundation awards $1.2M for research programs

The Parkinson's Disease Foundation (PDF) is pleased to announce awards totaling $1.2 million for research projects designed to understand the cause(s) of and find a cure for Parkinson's disease (PD).

2 Jul 2010

Frozen blood samples shows promise to study mechanism of blood disorders

Cells from frozen human blood samples can be reprogrammed to an embryonic-stem-cell-like state, according to Whitehead Institute researchers. These cells can be multiplied and used to study the genetic and molecular mechanisms of blood disorders and other diseases.

2 Jul 2010

Sun Pharma introduces generic rivastigmine capsules in U.S. market

Sun Pharma announced launch of generic Exelon, rivastigmine tartrate capsules for the US market. Earlier, USFDA had granted final approval for the Company's ANDA to market these products.

2 Jul 2010

Caraco Pharmaceutical Laboratories commences marketing of rivastigmine tartrate capsules

Caraco Pharmaceutical Laboratories, Ltd. has started shipping rivastigmine tartrate capsules. These products, approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA), are therapeutically equivalent to Exelon® capsules from Novartis.

2 Jul 2010

Governors urge Congress to extend emergency Medicaid funds

At a press conference in Washington Wednesday, "10 governors said they had already cut millions from their budgets since the recession hit at the end of 2007, and that if the funds were not approved in coming weeks they would have to slash funding for services like hospice care or preschool programs," Reuters reports.

2 Jul 2010

Governors to Congress: Restore extra Medicaid funds

Kaiser Health News staff writer Jenny Gold caught up with Kansas Gov. Mark Parkinson, a Democrat, after a Washington press conference to discuss the current enhanced federal share of Medicaid funds set to expire at the end of the year and the devastating impact on state budgets that Congress' failure to provide additional federal Medicaid assistance could have (Gold, 6/30).

2 Jul 2010

First Edition: July 1, 2010

Today's health policy headlines highlight news about the launch of a government health insurance web site and the start of the high-risk health insurance pools mandated in the health reform law.

1 Jul 2010

University College London neurology professor becomes first recipient of Lord Brain Memorial Medal

Andrew Lees, Professor of Neurology at University College London, is to be the first ever recipient of the Lord Brain Memorial Medal - awarded for the scientific contributions he has made to the field of movement disorders within the UK. He will receive the medal following his delivery of the inaugural Lord Brain Memorial Lecture; "Brainwashed by the Black Stuff," at Barts and The London Medical School on June 24, 2010.

1 Jul 2010

Researchers to study interventional endovascular therapy on symptoms and progression of MS

Buffalo medical researchers led by a team from the University at Buffalo Department of Neurosurgery, will embark on a landmark prospective randomized double-blinded study to test the safety and efficacy of interventional endovascular therapy -- dubbed "liberation treatment" -- on the symptoms and progression of Multiple Sclerosis.

1 Jul 2010

Mass. reports on people who buy insurance only when sick; Wash. board considers aiding consumers get 'Plan B' referrals; ACLU sues R.I. over electronic records

The Boston Globe: "The number of people who appear to be gaming the state's health insurance system by purchasing coverage only when they are sick quadrupled from 2006 to 2008, according to a long-awaited report released yesterday from the Massachusetts Division of Insurance. The result is that insured residents of Massachusetts wind up paying more for health care, according to the report. … The report was released as state lawmakers consider proposals to make it harder for consumers to jump in and then dump their health insurance coverage" (Lazar, 6/30).

1 Jul 2010

New guide to get pregnant

Infertility affects about 7 million Americans -- that's about one in six couples during their childbearing years. There are many reasons for infertility, with equal chances it's his medical issue as it is hers. A new book, "A Baby at Last!: The Couples' Complete Guide to Getting Pregnant" (Fireside Books, Simon and Schuster), points the way for couples to get past the emotionally wrenching obstacle of infertility and finally bring home their bundle of joy.

1 Jul 2010

Chelsea completes enrollment in Northera Phase III Study 301 for neurogenic orthostatic hypotension

Chelsea Therapeutics International, Ltd. has successfully reached its target enrollment of 150 patients in its Northera™ (Droxidopa) pivotal Phase III Study 301 for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH). Results from the trial are expected in September 2010 and the full registration program is on track to initiate a new drug application (NDA) in the first half of 2011.

30 Jun 2010

ERC awards VIB-K.U.Leuven scientists 3 million euros in research grants

VIB landed two research grants worth 1.5 million euros each. The prestigious grants are courtesy of the European Research Council (ERC) and are aimed at giving talented young scientists the opportunity to develop their own research team. The honor fell to Adrian Liston and Patrik Verstreken, both recently transferred to VIB-K.U.Leuven from abroad.

30 Jun 2010

Molecular Biometrics' ViaMetrics-E procedure accurately predicts implantation rates in SET IVF cycles

Researchers from Molecular Biometrics, Inc. presented new data this week demonstrating that the company's ViaMetrics-E procedure more accurately predicts implantation rates in single embryo transfer (SET) cycles for patients undergoing infertility treatment. ViaMetrics-E is a rapid, non-invasive procedure used to enhance in vitro fertilization (IVF) outcomes by identifying viable embryos having the greatest reproductive potential.

30 Jun 2010

Tel Aviv University develops method for tracking progression of adult stem cells

It's a new technology that uses molecular therapy to coax adult cells to revert to an embryonic stem cell-like state, allowing scientists to later re-differentiate these cells into specific types with the potential to treat heart attacks or diseases such as Parkinson's.

30 Jun 2010

Chelsea initiates NORTHERA Phase III trial for symptomatic NOH associated with PD

Chelsea Therapeutics International, Ltd. announced the initiation of Study 306, a pivotal Phase III trial evaluating the efficacy of NORTHERA™, an oral synthetic precursor of norepinephrine, for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) associated with Parkinson's disease.

29 Jun 2010

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Karolinska Institutet researchers contribute at ESOF 2010

VA to develop fully automated, online system for handling disability compensation claims

States anxiously hoping for extra Medicaid funds extension

XenoPort reports equity awards to new employee under Inducement Award Plan

Parkinson's Disease Foundation awards $1.2M for research programs

Frozen blood samples shows promise to study mechanism of blood disorders

Sun Pharma introduces generic rivastigmine capsules in U.S. market

Caraco Pharmaceutical Laboratories commences marketing of rivastigmine tartrate capsules

Governors urge Congress to extend emergency Medicaid funds

Governors to Congress: Restore extra Medicaid funds

First Edition: July 1, 2010

University College London neurology professor becomes first recipient of Lord Brain Memorial Medal

Researchers to study interventional endovascular therapy on symptoms and progression of MS

Mass. reports on people who buy insurance only when sick; Wash. board considers aiding consumers get 'Plan B' referrals; ACLU sues R.I. over electronic records

New guide to get pregnant

Chelsea completes enrollment in Northera Phase III Study 301 for neurogenic orthostatic hypotension

ERC awards VIB-K.U.Leuven scientists 3 million euros in research grants

Molecular Biometrics' ViaMetrics-E procedure accurately predicts implantation rates in SET IVF cycles

Tel Aviv University develops method for tracking progression of adult stem cells

Chelsea initiates NORTHERA Phase III trial for symptomatic NOH associated with PD

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in